Business Development Rep

• help to shape Johnson & Johnson’s scientific pipeline by optimizing for greater access when these therapies launch.
• a key role on SCG Value, Access, and Pricing (VAP) team which will integrate key capabilities in the early pipeline to shape success with Market Access (MA) customers in the U.S. market.
• advise on all pipeline compounds, line extensions, and indication expansions from Discovery through Phase 3 development and label submission.
• integrate a Market Access perspective into key pipeline decisions to support optimal payer coverage and patient access for new pipeline products when in market.
• serve as a key member of U.S. Integrated Strategy Team and collaborate with Global teams for assigned TA to shape pipeline compound strategy and inform stage gate decisions.
• generate insights to shape evidence strategy for the compound.
• assess & advise clinical, economic, humanistic evidence strategy to shape early value proposition and commercial plans from an Access perspective.
• model pricing & contracting to inform business planning & forecasts.
• advise on Business Development opportunities from an Access perspective as they arise.
• support transition to Commercial Launch teams (~18-24 mo. pre-launch).

Director, Market Access Strategy – New Products & Business Development, Solid Tumor

Finance Business Development Officer

Business Development Manager – Air Freight

Business Development Executive – Healthcare IT Solutions

Senior Strategy & Business Development Advisor, Independent Pharmacy